Clinical profile during the first and second pandemic waves in children and adolescents with COVID-19 at pediatric public hospital, Rio de Janeiro, Brazil
DOI:
https://doi.org/10.54034/mic.e1989Keywords:
children, adolescents, COVID-19, SARS-CoV-2, symptoms, mortalityAbstract
Background: COVID-19 is usually milder in children and adolescents, leading to lower hospital admission rates than adults. This study evaluated clinical manifestations in children (< 10 years) and adolescents (10 to < 18 years) with COVID-19 admitted to a tertiary municipal hospital in Rio de Janeiro (Brazil) during the first (February to November 2020) and second pandemic waves (November 2020 to April 2021). Methods: this retrospective observational study considered patients in the pediatric age group (<18 years old) with confirmed diagnosis of COVID-19 using RT-PCR. Descriptive and bivariate analysis were performed assuming a p-value<0.05 level of significance for all analyses. Results: among the 34 included patients (50% boys; 73.5% children), the most prevalent symptom was fever (88.2%), followed by asthenia (85.3%), and cough associated with dyspnea (50%); 29.4% were admitted to the ICU, and 5.9% needed invasive mechanical ventilation. All patients were treated with antibiotics, 88.2% with antivirals, and 52.9% with corticosteroids. Asthenia was more frequent among children than adolescents (96.0% vs. 55.6%; p < 0.01). Tuberculosis was observed in none of the children, but 33.3% of the adolescents (p-value = 0.003). The percentage of hospitalized patients with family members infected with SARS-CoV-2 was smaller among children than adolescents (8.0% vs. 44.0%; p-value = 0.01). Other variables that differed between children and adolescents were C-reactive protein, creatinine, and need for non-invasive mechanical ventilation. There were no deaths among participants. Conclusion: in our hospital, COVID-19 was most often not severe in children and adolescents. Overall, children were hospitalized more frequently by COVID-19 than adolescents, with some differences for clinical characteristics.
References
Howard‐Jones AR, Bowen AC, Danchin M, Koirala A, Sharma K, Yeoh DK, et al. COVID‐19 in children: I. Epidemiology, prevention and indirect impacts. Journal of Paediatrics and Child Health. 2021;58(1):39-45. doi: 10.1111/jpc.15791.
Jackson WM, Price JC, Eisler L, Sun LS, Lee JJ. COVID-19 in Pediatric Patients: A Systematic Review. Journal of Neurosurgical Anesthesiology. 2022;34(1):141-7. doi: 10.1097/ana.0000000000000803.
Tullie L, Ford K, Bisharat M, Watson T, Thakkar H, Mullassery D, et al. Gastrointestinal features in children with COVID-19: an observation of varied presentation in eight children. The Lancet Child & Adolescent Health. 2020;4(7):e19-e20. doi: 10.1016/s2352-4642(20)30165-6.
Calitri C, Fumi I, Ignaccolo MG, Banino E, Benetti S, Lupica MM, et al. Gastrointestinal involvement in paediatric COVID-19 — from pathogenesis to clinical management: A comprehensive review. World Journal of Gastroenterology. 2021;27(23):3303-16. doi: 10.3748/wjg.v27.i23.3303.
Mehraeen E, Oliaei S, SeyedAlinaghi S, Karimi A, Mirzapour P, Afsahi AM, et al. COVID-19 in Pediatrics: A Systematic Review of Current Knowledge and Practice. Infectious Disorders - Drug Targets. 2022;22(5). doi: 10.2174/1871526521666210929121705.
Preston LE, Chevinsky JR, Kompaniyets L, Lavery AM, Kimball A, Boehmer TK, et al. Characteristics and Disease Severity of US Children and Adolescents Diagnosed With COVID-19. JAMA Network Open. 2021;4(4):e215298. doi: 10.1001/jamanetworkopen.2021.5298.
Zhou B, Yuan Y, Wang S, Zhang Z, Yang M, Deng X, et al. Risk profiles of severe illness in children with COVID-19: a meta-analysis of individual patients. Pediatric Research. 2021;90(2):347-52. doi: 10.1038/s41390-021-01429-2.
Sousa BLA, Silva CA, Ferraro AA. An update on the epidemiology of pediatric COVID-19 in Brazil. Revista Paulista de Pediatria. 2022;40. doi: 10.1590/1984-0462/2022/40/2021367.
Silva ACCACd, Luiz RR, Moraes JRd, Rocha PHV, Zeitoune RCG, Barbosa AP, et al. Mortalidade hospitalar por covid-19 em crianças e adolescentes no Brasil em 2020–2021. Revista de Saúde Pública. 2023;57(1):56. doi: 10.11606/s1518-8787.2023057005172.
Zeiser FA, Donida B, da Costa CA, Ramos GdO, Scherer JN, Barcellos NT, et al. First and second COVID-19 waves in Brazil: A cross-sectional study of patients' characteristics related to hospitalization and in-hospital mortality. The Lancet Regional Health - Americas. 2022;6:100107. doi: 10.1016/j.lana.2021.100107.
Bundy DAP, de Silva N, Horton S, Patton GC, Schultz L, Jamison DT. Child and Adolescent Health and Development: Realizing Neglected Potential. 2017:1-24. doi: 10.1596/978-1-4648-0423-6_ch1.
Götzinger F, Santiago-García B, Noguera-Julián A, Lanaspa M, Lancella L, Calò Carducci FI, et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. The Lancet Child & Adolescent Health. 2020;4(9):653-61. doi: 10.1016/s2352-4642(20)30177-2.
Bain V, Abramczyk ML, Costa RLS, Paixão MR, Souza Junior JLd. Pediatric COVID-19: clinical and epidemiological data of 1303 cases in a general hospital in Brazil. Revista Paulista de Pediatria. 2024;42. doi: 10.1590/1984-0462/2024/42/2023031.
Oliveira EA, Colosimo EA, Simões e Silva AC, Mak RH, Martelli DB, Silva LR, et al. Clinical characteristics and risk factors for death among hospitalised children and adolescents with COVID-19 in Brazil: an analysis of a nationwide database. The Lancet Child & Adolescent Health. 2021;5(8):559-68. doi: 10.1016/s2352-4642(21)00134-6.
Mannheim J, Konda S, Logan LK. Racial, ethnic and socioeconomic disparities in SARS‐CoV‐2 infection amongst children. Paediatric and Perinatal Epidemiology. 2022;36(3):337-46. doi: 10.1111/ppe.12865.
Antoon JW, Grijalva CG, Thurm C, Richardson T, Spaulding AB, Ii RJT, et al. Factors Associated With COVID‐19 Disease Severity in US Children and Adolescents. Journal of Hospital Medicine. 2021;16(10):603-10. doi: 10.12788/jhm.3689.
Rahman MM, Bhattacharjee B, Farhana Z, Hamiduzzaman M, Chowdhury MAB, Hossain MS, et al. Age-related risk factors and severity of SARS-CoV-2 infection: a systematic review and meta-analysis. J Prev Med Hyg. 2021;62(2):E329-E71. doi: 10.15167/2421-4248/jpmh2021.62.2.1946. PubMed PMID: 34604574; PubMed Central PMCID: PMCPMC8451365.
Irfan O, Muttalib F, Tang K, Jiang L, Lassi ZS, Bhutta Z. Clinical characteristics, treatment and outcomes of paediatric COVID-19: a systematic review and meta-analysis. Archives of Disease in Childhood. 2021;106(5):440-8. doi: 10.1136/archdischild-2020-321385.
Biharie A, Keuning MW, Wolthers KC, Pajkrt D. Comorbidities, clinical characteristics and outcomes of COVID-19 in pediatric patients in a tertiary medical center in the Netherlands. World Journal of Pediatrics. 2022;18(8):558-63. doi: 10.1007/s12519-022-00564-y.
Uka A, Buettcher M, Bernhard-Stirnemann S, Fougère Y, Moussaoui D, Kottanattu L, et al. Factors associated with hospital and intensive care admission in paediatric SARS-CoV-2 infection: a prospective nationwide observational cohort study. European Journal of Pediatrics. 2021;181(3): 1245-55. doi: 10.1007/s00431-021-04276-9.
Rudan I, Adeloye D, Katikireddi SV, Murray J, Simpson C, Shah SA, et al. The COVID-19 pandemic in children and young people during 2020-2021: Learning about clinical presentation, patterns of spread, viral load, diagnosis and treatment. Journal of Global Health. 2021;11. doi: 10.7189/jogh.11.01010.
Souza TH, Nadal JA, Nogueira RJN, Pereira RM, Brandão MB. Clinical manifestations of children with COVID‐19: A systematic review. Pediatric Pulmonology. 2020;55(8): 1892-9. doi: 10.1002/ppul.24885.
Zheng F, Liao C, Fan Q-h, Chen H-b, Zhao X-g, Xie Z-g, et al. Clinical Characteristics of Children with Coronavirus Disease 2019 in Hubei, China. Current Medical Science. 2020;40(2):275-80. doi: 10.1007/s11596-020-2172-6.
Sherif EM, Elhenawy YI, Matter RM, Aly HH, Thabet RA, Fereig YA. Clinical characteristics and outcome of hospitalized children and adolescent patients with type 1 diabetes during the COVID-19 pandemic: data from a single center surveillance study in Egypt. Journal of Pediatric Endocrinology and Metabolism. 2021;34(7):925-36. doi: 10.1515/jpem-2021-0099.
Zaffanello M, Piacentini G, Nosetti L, Ganzarolli S, Franchini M. Thrombotic risk in children with COVID-19 infection: A systematic review of the literature. Thrombosis Research. 2021;205:92-8. doi: 10.1016/j.thromres.2021.07.011.
Noni M, Koukou D-M, Tritzali M, Kanaka-Gantenbein C, Michos A, Spoulou V. Coagulation Abnormalities and Management in Hospitalized Pediatric Patients With COVID-19. Pediatric Infectious Disease Journal. 2022;41(7):570-4. doi: 10.1097/inf.0000000000003545.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Jeferson Tobias da Silva de Oliveira de Oliveira, Luciana Fernandes Portela, Marcelo Carvalho Vieira, Mariana Cristina Mendes Almeida, Luiz Henrique Conde Sangenis, Ivonete Siviero, Tatiana Rehder Gonçalves, Mauro Felippe Felix Mediano

This work is licensed under a Creative Commons Attribution 4.0 International License.